Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Carter's Aromatherapy Designs (C.A.D.) has shown a consistent performance in the California market, particularly in the Tincture & Sublingual category. Despite maintaining a steady rank of 17th from September through November 2025, the brand experienced a slight dip to 18th in December. This decline in rank suggests increased competition or a slight decrease in market share within this category. However, it's worth noting that their sales figures have remained relatively stable, with a notable peak in October. This indicates that while their rank may have slipped slightly, consumer demand for their products remains strong.
In the Topical category, C.A.D. has consistently performed well, maintaining a top-five position throughout the last quarter of 2025. The brand ranked 4th in both September and October before moving to 5th place in November and December. This slight decrease in ranking does not overshadow the impressive sales growth observed, particularly in November, which suggests a successful marketing strategy or a positive reception of their product offerings during that period. The ability to maintain a high rank in a competitive market like California highlights C.A.D.'s strong presence and appeal in the Topical category, positioning them as a significant player in this segment.
Competitive Landscape
In the competitive landscape of the California Topical cannabis market, Carter's Aromatherapy Designs (C.A.D.) has demonstrated a stable yet slightly fluctuating presence from September to December 2025. Maintaining a consistent rank of 4th in September and October, C.A.D. experienced a slight dip to 5th place in November and December. This shift can be attributed to the dynamic performance of competitors like Sweet ReLeaf (CA), which climbed to 4th place in November, and Liquid Flower, which surged to 4th place in December. Despite these changes, C.A.D.'s sales have shown a positive trend, indicating a resilient market position amidst competitive pressures. Notably, Buddies consistently held the 3rd rank with significantly higher sales, underscoring the competitive challenge C.A.D. faces in climbing the ranks. Meanwhile, Care By Design maintained a steady 7th position, highlighting a less volatile competitive environment in the lower ranks. These insights suggest that while C.A.D. remains a strong contender, strategic efforts may be needed to regain and surpass its previous ranking positions.

Notable Products
In December 2025, the CBD/THC 2:1 Rasta Pain Cream (1000mg CBD, 500mg THC, 2oz) maintained its position as the top-selling product for Carter's Aromatherapy Designs (C.A.D.), with sales reaching 337 units. The CBD:THC 2:1 Mimosa Cream (215mg CBD, 130mg THC, 1.9oz) climbed back to second place, showing recovery after dropping to third in October. The CBD/THC Relaxation Tincture (13.6mg CBD, 530mg THC) ranked third, a slight decline from its second place in November. A new entry, the CBD/THC Balance Tincture (650mg CBD, 20mg THC), appeared in fourth place, indicating strong initial performance. Lastly, the CBN:CBD:THC Cooling Transdermal Patch (30mg CBD, 25mg CBN, 25mg THC) rounded out the top five, marking its first appearance in the rankings since September.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






